220 related articles for article (PubMed ID: 26053181)
1. MicroRNA-106b inhibits osteoclastogenesis and osteolysis by targeting RANKL in giant cell tumor of bone.
Wang T; Yin H; Wang J; Li Z; Wei H; Liu Z; Wu Z; Yan W; Liu T; Song D; Yang X; Huang Q; Zhou W; Xiao J
Oncotarget; 2015 Aug; 6(22):18980-96. PubMed ID: 26053181
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-16-5p Inhibits Osteoclastogenesis in Giant Cell Tumor of Bone.
Sang S; Zhang Z; Qin S; Li C; Dong Y
Biomed Res Int; 2017; 2017():3173547. PubMed ID: 28589137
[TBL] [Abstract][Full Text] [Related]
3. MiR-126-5p regulates osteoclast differentiation and bone resorption in giant cell tumor through inhibition of MMP-13.
Wu Z; Yin H; Liu T; Yan W; Li Z; Chen J; Chen H; Wang T; Jiang Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Jan; 443(3):944-9. PubMed ID: 24360951
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-223 and miR-19a induces differentiation and promotes recruitment of osteoclast cells in giant-cell tumor of the bone via the Runx2/TWIST-RANK/RANKL pathway.
Jiang ZY; Jiang JJ; Ma YS; Li HY; Shi W; Fu PL; Xu CF; Lu JZ; Fu D; Xu JG
Biochem Biophys Res Commun; 2018 Nov; 505(4):1003-1009. PubMed ID: 30309658
[TBL] [Abstract][Full Text] [Related]
5. MiR-30a inhibits osteolysis by targeting RunX2 in giant cell tumor of bone.
Huang Q; Jiang Z; Meng T; Yin H; Wang J; Wan W; Cheng M; Yan W; Liu T; Song D; Chen H; Wu Z; Xu W; Li Z; Zhou W; Xiao J
Biochem Biophys Res Commun; 2014 Oct; 453(1):160-5. PubMed ID: 25264196
[TBL] [Abstract][Full Text] [Related]
6. MiR-377 inhibits wear particle-induced osteolysis via targeting RANKL.
Li W; Wang X; Chang L; Wang F
Cell Biol Int; 2019 Jun; 43(6):658-668. PubMed ID: 30958621
[TBL] [Abstract][Full Text] [Related]
7. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
Cowan RW; Singh G; Ghert M
J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
[TBL] [Abstract][Full Text] [Related]
8. TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone.
Wang T; Jiao J; Zhang H; Zhou W; Li Z; Han S; Wang J; Yang X; Huang Q; Wu Z; Yan W; Xiao J
Int J Cancer; 2017 Oct; 141(8):1630-1642. PubMed ID: 28670703
[TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer binding protein beta is up-regulated in giant cell tumor of bone and regulates RANKL expression.
Ng PK; Tsui SK; Lau CP; Wong CH; Wong WH; Huang L; Kumta SM
J Cell Biochem; 2010 May; 110(2):438-46. PubMed ID: 20225273
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel inhibits osteoclast formation and bone resorption via influencing mitotic cell cycle arrest and RANKL-induced activation of NF-κB and ERK.
Ang ES; Pavlos NJ; Chim SM; Feng HT; Scaife RM; Steer JH; Zheng MH; Xu J
J Cell Biochem; 2012 Mar; 113(3):946-55. PubMed ID: 22034016
[TBL] [Abstract][Full Text] [Related]
11. MiR-126-5p regulates osteolysis formation and stromal cell proliferation in giant cell tumor through inhibition of PTHrP.
Zhou W; Yin H; Wang T; Liu T; Li Z; Yan W; Song D; Chen H; Chen J; Xu W; Yang X; Wu Z; Xiao J
Bone; 2014 Sep; 66():267-76. PubMed ID: 24973691
[TBL] [Abstract][Full Text] [Related]
12. Sustained autocrine induction and impaired negative feedback of osteoclastogenesis in CD14(+) cells of giant cell tumor of bone.
Avnet S; Salerno M; Zini N; Alberghini M; Gibellini D; Baldini N
Am J Pathol; 2013 Apr; 182(4):1357-66. PubMed ID: 23395086
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluoruracil blocked giant cell tumor progression by suppressing osteoclastogenesis through NF-kappaB signals and blocking angiogenesis.
Song D; Meng T; Xu W; Hou T; Lin Z; Yin H; Li B; Zhou L; Wang T; Han S; Fan T; Miao W; Liu M; Luo J; Zhou W; Li Z; Xiao J
Bone; 2015 Sep; 78():46-54. PubMed ID: 25956534
[TBL] [Abstract][Full Text] [Related]
15. MiR-106b inhibition suppresses inflammatory bone destruction of wear debris-induced periprosthetic osteolysis in rats.
Yu B; Bai J; Shi J; Shen J; Guo X; Liu Y; Ge G; Lin J; Tao Y; Yang H; Xu Y; Qu Q; Geng D
J Cell Mol Med; 2020 Jul; 24(13):7490-7503. PubMed ID: 32485091
[TBL] [Abstract][Full Text] [Related]
16. MiR-503 regulates osteoclastogenesis via targeting RANK.
Chen C; Cheng P; Xie H; Zhou HD; Wu XP; Liao EY; Luo XH
J Bone Miner Res; 2014 Feb; 29(2):338-47. PubMed ID: 23821519
[TBL] [Abstract][Full Text] [Related]
17. Receptor-Activator of Nuclear KappaB Ligand Expression as a New Therapeutic Target in Primary Bone Tumors.
Yamagishi T; Kawashima H; Ogose A; Ariizumi T; Sasaki T; Hatano H; Hotta T; Endo N
PLoS One; 2016; 11(5):e0154680. PubMed ID: 27163152
[TBL] [Abstract][Full Text] [Related]
18. Expression of osteoclast differentiation signals by stromal elements of giant cell tumors.
Atkins GJ; Haynes DR; Graves SE; Evdokiou A; Hay S; Bouralexis S; Findlay DM
J Bone Miner Res; 2000 Apr; 15(4):640-9. PubMed ID: 10780856
[TBL] [Abstract][Full Text] [Related]
19. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern.
Stagner AM; Sajed DP; Nielsen GP; Ebb DH; Faquin WC; Chebib I; Rivera MN; Ting DT; Resnick CM; Peacock ZS; Kaban LB; Deshpande V
Am J Surg Pathol; 2019 Jun; 43(6):819-826. PubMed ID: 30998511
[TBL] [Abstract][Full Text] [Related]
20. Triptolide inhibits osteoclast formation, bone resorption, RANKL-mediated NF-қB activation and titanium particle-induced osteolysis in a mouse model.
Huang J; Zhou L; Wu H; Pavlos N; Chim SM; Liu Q; Zhao J; Xue W; Tan RX; Ye J; Xu J; Ang ES; Feng H; Tickner J; Xu J; Ding Y
Mol Cell Endocrinol; 2015 Jan; 399():346-53. PubMed ID: 25448849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]